Humanigen
Humanigen is a monoclonal antibody for cancer founded in 2001.
2
Funding Rounds
$29.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca***** Du***** | - | - | |
| Jo** Ho****** | - | - | - |
| Ra**** Bo*** | - | - | - |
| Da** Ch****** | - | - | - |
| Ro**** Ba****** | - | - | - |
| Ch**** Bu**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Humanigen has raised a total of $29m in funding over 2 rounds.
Key Insights:
- Humanigen funding round, April 2012: $17m
- Humanigen Series D round: $12m
Humanigen funding round, April 2012
$17m
Humanigen Series D round
$12m
Industries
Humanigen is active in the following industries: